CME Group Inc. $CME Shares Acquired by Brooklyn Investment Group

Brooklyn Investment Group lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 20.9% during the first quarter, HoldingsChannel.com reports. The firm owned 1,672 shares of the financial services provider’s stock after purchasing an additional 289 shares during the period. Brooklyn Investment Group’s holdings in CME Group were worth $444,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in CME. Heartland Bank & Trust Co purchased a new stake in shares of CME Group in the 1st quarter worth about $377,000. Catalyst Capital Advisors LLC boosted its position in shares of CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after buying an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. purchased a new stake in shares of CME Group in the 1st quarter worth about $367,000. Fulcrum Equity Management purchased a new stake in shares of CME Group in the 1st quarter worth about $258,000. Finally, AIA Group Ltd boosted its position in shares of CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after buying an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, Director Charles P. Carey sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director owned 4,900 shares in the company, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard purchased 256 shares of the business’s stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director directly owned 258,196 shares of the company’s stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their position. The disclosure for this purchase can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Trading Down 1.3%

Shares of CME stock opened at $270.41 on Tuesday. The firm has a market cap of $97.45 billion, a P/E ratio of 26.18, a PEG ratio of 4.86 and a beta of 0.44. CME Group Inc. has a 1-year low of $206.44 and a 1-year high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm’s 50-day simple moving average is $275.56 and its 200-day simple moving average is $267.83.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.56 EPS. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 48.40%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Oppenheimer boosted their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Morgan Stanley boosted their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research report on Thursday, April 24th. Barclays set a $298.00 price target on shares of CME Group and gave the stock an “equal weight” rating in a research note on Thursday, July 24th. UBS Group reaffirmed a “neutral” rating and set a $305.00 price target on shares of CME Group in a research note on Thursday, July 24th. Finally, JPMorgan Chase & Co. decreased their price target on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating on the stock in a research note on Thursday, April 24th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $261.93.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.